Abbott agreed to enter into a consent decree with the U.S. Food and Drug Administration related to the company’s Sturgis, Mich., infant formula plant. The decree is an agreement between the FDA and Abbott on the steps necessary to resume production and maintain the facility. This does not affect any other Abbott plant or operation. The decree is subject to court approval.

The discovery of the Omicron variant in white-tailed deer in New York raised concerns that the species – numbering 30 million in the United States – could become hosts of a new coronavirus strain, a lead researcher said on February 8.